Evaxion Biotech Files April 2025 6-K Report
Ticker: EVAX · Form: 6-K · Filed: Apr 29, 2025 · CIK: 1828253
| Field | Detail |
|---|---|
| Company | Evaxion Biotech A/S (EVAX) |
| Form Type | 6-K |
| Filed Date | Apr 29, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: reporting, foreign-private-issuer, registration-statement
TL;DR
Evaxion Biotech filed its April 6-K, incorporating prior filings. No new material info.
AI Summary
Evaxion Biotech A/S filed a Form 6-K on April 29, 2025, to report for the month of April 2025. The filing incorporates by reference previous registration statements on Forms S-8 and F-3, as well as multiple amended Form F-1 filings. The company is a foreign private issuer incorporated in G7 with its principal executive offices located at Dr. Neergaards Vej 5f, DK-2970 Hoersholm, Denmark.
Why It Matters
This filing serves as an update for Evaxion Biotech A/S, incorporating previous registration statements and providing information relevant to its ongoing reporting obligations as a foreign private issuer.
Risk Assessment
Risk Level: low — This is a routine reporting form (6-K) that incorporates previous filings, indicating no new significant events or disclosures.
Key Players & Entities
- Evaxion Biotech A/S (company) — Registrant
- Dr. Neergaards Vej 5f, DK-2970 Hoersholm, Denmark (location) — Principal executive offices
- 001-39950 (other) — Commission File Number
- 333-255064 (other) — Form S-8 File Number
- 333-265132 (other) — Form F-3 File Number
- 333-266050 (other) — Amended Form F-1 File Number
- 333-276505 (other) — Form F-1 File Number
- 333-279153 (other) — Form F-1 File Number
- 333-283304 (other) — Form F-1 File Number
- 333-285778 (other) — Form F-3 File Number
FAQ
What is the purpose of this Form 6-K filing?
This Form 6-K report is filed by Evaxion Biotech A/S for the month of April 2025 and is incorporated by reference into various registration statements.
What is Evaxion Biotech A/S's primary business classification?
Evaxion Biotech A/S is classified under 'BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES)' with SIC code 2836.
Where are Evaxion Biotech A/S's principal executive offices located?
The principal executive offices are located at Dr. Neergaards Vej 5f, DK-2970 Hoersholm, Denmark.
Which registration statements does this 6-K filing incorporate by reference?
This filing is incorporated by reference into Evaxion Biotech A/S's registration statements on Form S-8 (File No. 333-255064), Form F-3 (File No. 333-265132), multiple amended Form F-1 filings, and other Form F-3 filings.
Is Evaxion Biotech A/S required to file annual reports under Form 20-F or 40-F?
Evaxion Biotech A/S indicates it files annual reports under cover of Form 20-F.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on April 29, 2025 regarding Evaxion Biotech A/S (EVAX).